Trung Huynh
Stock Analyst at UBS
(1.74)
# 1016
Out of 5,298 analysts
35
Total ratings
52.17%
Success rate
19.86%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
CABA Cabaletta Bio | Maintains: Buy | 10 7 | 1.16 | 503.45% | 2 | Apr 1, 2025 | |
INSM Insmed | Maintains: Strong Buy | 105 110 | 69.01 | 59.4% | 4 | Mar 6, 2025 | |
JSPR Jasper Therapeutics | Initiates Coverage On: Buy | 38 | 3.77 | 907.96% | 1 | Feb 13, 2025 | |
CLDX Celldex Therapeutics | Initiates Coverage On: Buy | 44 | 15.86 | 177.43% | 1 | Feb 13, 2025 | |
REGN Regeneron Pharmaceut... | Downgrades: Neutral | 1130 738 | 585.51 | 26.04% | 1 | Jan 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 13 | 1.92 | 577.08% | 1 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 50 54 | 55.03 | -1.87% | 4 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Strong Buy | 612 710 | 740.95 | -4.18% | 7 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 170 175 | 153.9 | 13.71% | 2 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 220 200 | 296.5 | -32.55% | 3 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 47 40 | 23.11 | 73.09% | 4 | Jun 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 125 126 | 81.32 | 54.94% | 3 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 170 | 189.15 | -10.12% | 1 | Nov 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | n/a | n/a | n/a | 1 | Mar 23, 2021 |